vs
Copart（CPRT）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Copart的1.2倍（$1.4B vs $1.2B），Copart净利率更高（35.0% vs 27.6%，领先7.4%），瑞思迈同比增速更快（11.0% vs 0.7%），Copart自由现金流更多（$427.2M vs $311.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 6.4%）
Copart是一家跨国在线车辆拍卖及再营销服务提供商，服务保险、租车、车队、金融公司等各类汽车经销商，业务覆盖美国、加拿大、英国、德国等11个国家。总部位于美国得克萨斯州达拉斯，拥有200多处实体网点，运营总面积超1万英亩的车辆存放场地。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CPRT vs RMD — 直观对比
营收规模更大
RMD
是对方的1.2倍
$1.2B
营收增速更快
RMD
高出10.3%
0.7%
净利率更高
CPRT
高出7.4%
27.6%
自由现金流更多
CPRT
多$116.0M
$311.2M
两年增速更快
RMD
近两年复合增速
6.4%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.4B |
| 净利润 | $403.7M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 37.3% | 34.6% |
| 净利率 | 35.0% | 27.6% |
| 营收同比 | 0.7% | 11.0% |
| 净利润同比 | 11.5% | 13.9% |
| 每股收益（稀释后） | $0.41 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPRTRMD
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.0B | $1.2B |
净利润CPRTRMD
| Q4 25 | $403.7M | $392.6M | ||
| Q3 25 | $396.4M | $348.5M | ||
| Q2 25 | $406.6M | $379.7M | ||
| Q1 25 | $387.4M | $365.0M | ||
| Q4 24 | $362.1M | $344.6M | ||
| Q3 24 | $322.6M | $311.4M | ||
| Q2 24 | $382.3M | $292.2M | ||
| Q1 24 | $325.6M | $300.5M |
毛利率CPRTRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率CPRTRMD
| Q4 25 | 37.3% | 34.6% | ||
| Q3 25 | 36.7% | 33.4% | ||
| Q2 25 | 37.3% | 33.7% | ||
| Q1 25 | 36.6% | 33.0% | ||
| Q4 24 | 35.4% | 32.5% | ||
| Q3 24 | 33.6% | 31.6% | ||
| Q2 24 | 38.8% | 31.2% | ||
| Q1 24 | 37.2% | 31.3% |
净利率CPRTRMD
| Q4 25 | 35.0% | 27.6% | ||
| Q3 25 | 35.2% | 26.1% | ||
| Q2 25 | 33.6% | 28.2% | ||
| Q1 25 | 33.3% | 28.3% | ||
| Q4 24 | 31.6% | 26.9% | ||
| Q3 24 | 30.2% | 25.4% | ||
| Q2 24 | 33.9% | 23.9% | ||
| Q1 24 | 31.9% | 25.1% |
每股收益（稀释后）CPRTRMD
| Q4 25 | $0.41 | $2.68 | ||
| Q3 25 | $0.40 | $2.37 | ||
| Q2 25 | $0.42 | $2.58 | ||
| Q1 25 | $0.40 | $2.48 | ||
| Q4 24 | $0.37 | $2.34 | ||
| Q3 24 | $0.34 | $2.11 | ||
| Q2 24 | $0.39 | $1.97 | ||
| Q1 24 | $0.33 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $9.6B | $6.3B |
| 总资产 | $10.6B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CPRTRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $932.7M | ||
| Q4 24 | — | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | — | $237.9M |
总债务CPRTRMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | $0 | $667.6M | ||
| Q2 24 | $427.0K | $697.3M | ||
| Q1 24 | $453.0K | $997.0M |
股东权益CPRTRMD
| Q4 25 | $9.6B | $6.3B | ||
| Q3 25 | $9.2B | $6.1B | ||
| Q2 25 | $8.8B | $6.0B | ||
| Q1 25 | $8.3B | $5.5B | ||
| Q4 24 | $7.9B | $5.3B | ||
| Q3 24 | $7.5B | $5.2B | ||
| Q2 24 | $7.2B | $4.9B | ||
| Q1 24 | $6.8B | $4.6B |
总资产CPRTRMD
| Q4 25 | $10.6B | $8.5B | ||
| Q3 25 | $10.1B | $8.3B | ||
| Q2 25 | $9.7B | $8.2B | ||
| Q1 25 | $9.2B | $7.6B | ||
| Q4 24 | $8.9B | $7.1B | ||
| Q3 24 | $8.4B | $7.2B | ||
| Q2 24 | $8.0B | $6.9B | ||
| Q1 24 | $7.6B | $6.8B |
负债/权益比CPRTRMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | 0.00× | 0.13× | ||
| Q2 24 | 0.00× | 0.14× | ||
| Q1 24 | 0.00× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $535.3M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $427.2M | $311.2M |
| 自由现金流率自由现金流/营收 | 37.0% | 21.9% |
| 资本支出强度资本支出/营收 | 9.4% | 2.0% |
| 现金转化率经营现金流/净利润 | 1.33× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $1.4B | $1.8B |
8季度趋势，按日历期对齐
经营现金流CPRTRMD
| Q4 25 | $535.3M | $339.7M | ||
| Q3 25 | $438.5M | $457.3M | ||
| Q2 25 | $700.9M | $538.8M | ||
| Q1 25 | $178.1M | $578.7M | ||
| Q4 24 | $482.3M | $308.6M | ||
| Q3 24 | $439.2M | $325.5M | ||
| Q2 24 | $496.3M | $440.1M | ||
| Q1 24 | $161.8M | $402.0M |
自由现金流CPRTRMD
| Q4 25 | $427.2M | $311.2M | ||
| Q3 25 | $350.8M | $414.4M | ||
| Q2 25 | $572.9M | $508.2M | ||
| Q1 25 | $61.5M | $557.9M | ||
| Q4 24 | $245.5M | $288.0M | ||
| Q3 24 | $301.3M | $307.7M | ||
| Q2 24 | $408.5M | $415.2M | ||
| Q1 24 | $38.8M | $380.8M |
自由现金流率CPRTRMD
| Q4 25 | 37.0% | 21.9% | ||
| Q3 25 | 31.2% | 31.0% | ||
| Q2 25 | 47.3% | 37.7% | ||
| Q1 25 | 5.3% | 43.2% | ||
| Q4 24 | 21.4% | 22.5% | ||
| Q3 24 | 28.2% | 25.1% | ||
| Q2 24 | 36.2% | 33.9% | ||
| Q1 24 | 3.8% | 31.8% |
资本支出强度CPRTRMD
| Q4 25 | 9.4% | 2.0% | ||
| Q3 25 | 7.8% | 3.2% | ||
| Q2 25 | 10.6% | 2.3% | ||
| Q1 25 | 10.0% | 1.6% | ||
| Q4 24 | 20.6% | 1.6% | ||
| Q3 24 | 12.9% | 1.5% | ||
| Q2 24 | 7.8% | 2.0% | ||
| Q1 24 | 12.1% | 1.8% |
现金转化率CPRTRMD
| Q4 25 | 1.33× | 0.87× | ||
| Q3 25 | 1.11× | 1.31× | ||
| Q2 25 | 1.72× | 1.42× | ||
| Q1 25 | 0.46× | 1.59× | ||
| Q4 24 | 1.33× | 0.90× | ||
| Q3 24 | 1.36× | 1.05× | ||
| Q2 24 | 1.30× | 1.51× | ||
| Q1 24 | 0.50× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRT
| Services | $952.1M | 82% |
| Other | $203.0M | 18% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
